Metraipolis › archive › dc_d1dbceae1d99
Protein tyrosine phosphatase 1B as a therapeutic target for Graves' orbitopathy in an in vitro model — Europe PMC PMID:32760098
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/32760098
- DOI
- 10.1371/journal.pone.0237015
- License (as archived)
- CC0-1.0
- Archived
- 2026-11-07T21:05:09.947Z
- SHA-256 of the archived text
91837c5c5e0bae73f29688555c18600dcae8a4855a596063293c7d6334235cd5- Stable URL of this page
https://metraipolis.com/documento/dc_d1dbceae1d99
How to cite
Protein tyrosine phosphatase 1B as a therapeutic target for Graves' orbitopathy in an in vitro model — Europe PMC PMID:32760098 — Europe PMC (en), https://europepmc.org/article/MED/32760098 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_d1dbceae1d99 (Metraipolis archive dc_d1dbceae1d99, sha256 91837c5c5e0bae73f29688555c18600dcae8a4855a596063293c7d6334235cd5)
BibTeX
@misc{dcd1dbceae1d99,
title = {Protein tyrosine phosphatase 1B as a therapeutic target for Graves' orbitopathy in an in vitro model — Europe PMC PMID:32760098},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/32760098},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_d1dbceae1d99; sha256 91837c5c5e0bae73f29688555c18600dcae8a4855a596063293c7d6334235cd5},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/32760098. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Graves' orbitopathy (GO) is characterised in early stages by orbital fibroblast inflammation, which can be aggravated by oxidative stress and often leads to fibrosis. Protein tyrosine protein 1B (PTP1B) is a regulator of inflammation and a therapeutic target in diabetes. We investigated the role of PTP1B in the GO mechanism using orbital fibroblasts from GO and healthy non-GO subjects. After 24 hours of transfection with PTPN1 siRNA, the fibroblasts were exposed to interleukin (IL)-1β, cigarette smoke extract (CSE), H2O2, and transforming growth factor (TGF)-β stimulations. Inflammatory cytokines and fibrosis-related proteins were analysed using western blotting and/or enzyme-linked immunosorbent assay (ELISA). Reactive oxygen species (ROS) release was detected using an oxidant-sensitive fluorescent probe. IL-1β, tumor necrosis factor (TNF)-α, bovine thyroid stimulating hormone (bTSH), high-affinity human stimulatory monoclonal antibody of TSH receptor (M22), and insulin-like growth factor-1 (IGF-1) significantly increased PTP1B protein production in GO and non-GO fibroblasts. PTPN1 silencing significantly blocked IL-1β-induced inflammatory cytokine production, CSE- and H2O2-induced ROS synthesis, and TGF-β-induced expression of collagen Iα, α-smooth muscle actin (SMA), and fibronectin in GO fibroblasts. Silencing PTPN1 also decreased phosphorylation levels of Akt, p38, and c-Jun N-terminal kinase (JNK) and endoplasmic reticulum (ER)-stress response proteins in GO cells. PTP1B may be a potential therapeutic target of anti-inflammatory, anti-oxidant and anti-fibrotic treatment of GO. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PloS one, 2020 (prima pubblicazione 2020-08-06). Identificativi: PMID 32760098 · PMCID PMC7410323 · DOI 10.1371/journal.pone.0237015. Pagina: https://europepmc.org/article/MED/32760098 — https://doi.org/10.1371/journal.pone.0237015. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-11-07T21:01:33.442Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.